Botanical species · safety record

Aspalathus linearis

The EFSA Compendium of Botanicals holds 8 constituent measurements and 1 adverse-effect record for Aspalathus linearis. This page reports what those source records contain and how to reach them. It carries no effect estimate, no dose and no recommendation.

Accepted name in source: Aspalathus linearis (Burm.f.) R.Dahlgren

8Constituent measurements

1Safety records

5Cited sources

23Licensed products (Canada)

Regulatory presence

Health Canada's Licensed Natural Health Products Database holds 23 licensed products naming Aspalathus linearis as a medicinal ingredient, matched on the exact Latin binomial. A licence records that a product met the regulator's requirements for sale in Canada. It is not evidence that the product works.

Extract types on licence

Dry
Extract Type TBA

Source material stated

Aerial parts
Aspalathus linearis - Leaf
Leaf
Leaves
Stem
Stem and leaves
Stem(s)
Whole plant

What the records describe

Constituents measured

Plant parts

Preparations

Effect types

Target tissues

Recorded constituents

What analytical work has found in this species, at which plant part and preparation. A measured constituent is a fact about material, not about effect.

Substance	Plant part	Preparation	Concentration	Analytical method	Source
Eugenol	Leaves	Solvent extraction	—	GC-MS	Resolve DOI
Furan derivatives	Leaves	Solvent extraction	—	GC-MS	Resolve DOI
Furan derivatives	Aerial part of plants	Solvent extraction	—	—	Resolve DOI
Furfural	Leaves	Solvent extraction	—	GC-MS	Resolve DOI
Naphthalene	Leaves	Solvent extraction	—	GC-MS	Resolve DOI
Tannins	Leaves	Solvent extraction	—	Traditional analytical techniques (wet chemical tests)	Resolve DOI
Retrorsine	Leaves	Solvent extraction	—	LC-MS/MS	No resolvable identifier
Senecionine	Leaves	Solvent extraction	—	LC-MS/MS	No resolvable identifier

Recorded adverse effects

Adverse effects reported in the source literature, most often in animal or laboratory models at a stated preparation and dose.

Effect	Target tissue	Plant part	Preparation	Test organism	Test type	Source
Hepatotoxicity	Liver	Leaves	Solvent extraction	Human (as organism)	Case report	Resolve DOI

Cited sources

The literature the compendium cites for this species. Metatron Health has no relationship with these authors or journals and earns nothing from citing them.

KAWAKAMI, M., KOBAYASHI, A., KATOR, K. VOLATILE CONSTITUENTS OF ROOIBOS TEA (ASPALATHUS-LINEARIS) AS AFFECTED BY EXTRACTION PROCESS . Journal of agricultural and food chemistry, 1993, vol. 41, no. 4, p. 633-636. DOI
Mathon, Caroline., Edder, Patrick., Bieri, Stefan., Christen, Philippe. Survey of pyrrolizidine alkaloids in teas and herbal teas on the Swiss market using HPLC-MS/MS.. Analytical and bioanalytical chemistry, 2014, vol. 406, no. 28, p. 7345-7354.
Joubert, E., Winterton, P., Britz, TJ., Ferreira, D. Superoxide anion and alpha, alpha-diphenyl-beta-picrylhydrazyl radical scavenging capacity of rooibos (Aspalathus linearis) aqueous extracts, crude phenolic fractions, tannin and flavonoids . Food research international, 2004, vol. 37, no. 2, p. 133-138. DOI
Sinisalo, Marjatta., Enkovaara, Anna-Liisa., Kivisto, Kari T. Possible hepatotoxic effect of rooibos tea: a case report. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2010, vol. 66, no. 4, p. 427-428. DOI
Lasekan, O., Lasekan, A. Flavour chemistry of mate and some common herbal teas. TRENDS IN FOOD SCIENCE & TECHNOLOGY, 2012, vol. 27, no. 1, p. 37-46. DOI

Boundary

A constituent measurement is a fact about material at a stated preparation, not a statement about what that material does in a person. An adverse-effect or genotoxicity record is an observation reported in a source, most often in an animal or laboratory model. Neither is a Metatron Health conclusion about causality, human risk or benefit, and the absence of a record is not proof that a preparation is safe. Nothing here is diagnosis, prescribing or individual medical care.

Continue

Independent literature